New insights into cirrhotic cardiomyopathy

Kowalski, 1953, The cardiac output at rest in Laennecs cirrhosis, J Clin Invest, 32, 1025, 10.1172/JCI102813 Møller, 2008, Cardiovascular complications of cirrhosis, Gut, 57, 268, 10.1136/gut.2006.112177 Iwakiri, 2007, The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension, J Clin Gastroenterol, 41, S288, 10.1097/MCG.0b013e3181468b4c Schrier, 2006, Water and sodium retention in edematous disorders: role of vasopressin and aldosterone, Am J Med, 119, S47, 10.1016/j.amjmed.2006.05.007 Møller, 2010, Cirrhotic cardiomyopathy, J Hepatol, 53, 179, 10.1016/j.jhep.2010.02.023 Liu, 2011, Acute-on-chronic liver failure: the heart and systemic hemodynamics, Curr Opin Crit Care, 14, 190, 10.1097/MCC.0b013e328344b397 Timoh, 2011, A perspective on cirrhotic cardiomyopathy, Transplant Proc, 43, 1649, 10.1016/j.transproceed.2011.01.188 Zambruni, 2007, QT interval correction in patients with cirrhosis, J Cardiovasc Electrophysiol, 18, 77, 10.1111/j.1540-8167.2006.00622.x Wong, 2011, Prevalence of diastolic dysfunction in cirrhosis and its clinical significance, Hepatology, 54, 475A Karagiannakis, 2011, Cirrhotic cardiomyopathy: frequency, characteristics and relationship with bacterial translocation, Hepatology, 54, 1248A Desai, 2011, Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation, Gastroenterology, 141, 1264, 10.1053/j.gastro.2011.06.082 Kazankov, 2011, Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging, Liver Int, 31, 534, 10.1111/j.1478-3231.2011.02468.x Heuer, 2011, High rate of cardiac abnormalities in a post-mortem analysis of patients suffering from liver cirrhosis, J Hepatol, 54, S68 Schrier, 2001, Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis, Mt Sinai J Med, 68, 350 Møller, 2005, The systemic circulation in cirrhosis, 139 Møller, 2007, Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems, Am J Physiol Heart Circ Physiol, 292, H2966, 10.1152/ajpheart.01227.2006 Møller, 2003, Central- and non-central blood volumes in cirrhosis. Relation to anthropometrics and gender, Am J Physiol Gastrointest Liver Physiol, 284, G970, 10.1152/ajpgi.00521.2002 Wiest, 2002, The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough, Hepatology, 35, 478, 10.1053/jhep.2002.31432 Lagi, 2002, Impaired sympathetic regulation of cerebral blood flow in patients with cirrhosis of the liver, Clin Sci (Lond), 103, 43, 10.1042/CS20010316 Møller, 2009, Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension, Liver Int, 29, 1528, 10.1111/j.1478-3231.2009.02103.x Møller, 2011, Cardiorenal syndrome — a new entity?, 102 Møller, 2011, Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis, Gut, 1254, 10.1136/gut.2010.235473 Rössle, 2011, Hyperdynamic circulation and portal hypertension: chicken or egg?, Gut, 1167, 10.1136/gut.2011.242511 Glenn, 2011, Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats, J Hepatol, 55, 1249, 10.1016/j.jhep.2011.02.030 Lee, 1990, Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats, Hepatology, 12, 481, 10.1002/hep.1840120306 Barriere, 2001, Role of small-conductance Ca2+‐dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis, J Hepatol, 35, 350, 10.1016/S0168-8278(01)00141-6 Ma, 1997, Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy, J Hepatol, 26, 904, 10.1016/S0168-8278(97)80259-0 Mani, 2006, Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis, Hepatology, 43, 847, 10.1002/hep.21115 Gaskari, 2006, Therapy insight: cirrhotic cardiomyopathy, Nat Clin Pract Gastroenterol Hepatol, 3, 329, 10.1038/ncpgasthep0498 Ceolotto, 2008, An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats, Hepatology, 48, 1913, 10.1002/hep.22533 Mallat, 2011, The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings, Br J Pharmacol, 163, 1432, 10.1111/j.1476-5381.2011.01397.x Gaskari, 2005, Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats, Br J Pharmacol, 146, 315, 10.1038/sj.bjp.0706331 Liu, 2000, Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats, Gastroenterology, 118, 937, 10.1016/S0016-5085(00)70180-6 Schrier, 2007, Decreased effective blood volume in edematous disorders: what does this mean?, J Am Soc Nephrol, 18, 2028, 10.1681/ASN.2006111302 Wong, 2001, The cardiac response to exercise in cirrhosis, Gut, 49, 268, 10.1136/gut.49.2.268 Wong, 2009, Cirrhotic cardiomyopathy, Hep Intl, 3, 294, 10.1007/s12072-008-9109-7 Limas, 1977, Impaired left ventricular function in alcoholic cirrhosis with ascites, J Lab Clin Med, 89, 1175 Fouad, 2009, Prediction of cardiac complications after liver transplantation, Transplantation, 87, 763, 10.1097/TP.0b013e318198d734 Krag, 2010, Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis, Eur J Gastroenterol Hepatol, 22, 1085, 10.1097/MEG.0b013e32833a4822 WGJr, 1990, Atrial volume in cirrhosis: relationship to blood volume and plasma concentrations of atrial natriuretic factor, Gastroenterology, 99, 766, 10.1016/0016-5085(90)90966-5 Møller, 1995, Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis, Hepatology, 22, 472 Pouriki, 2011, Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome, Liver Int, 31, 1388, 10.1111/j.1478-3231.2011.02591.x Castellanos-Pallares, 2011, Anatomical cardiac alterations in liver cirrhosis: an autopsy study, Ann Hepatol, 10, 321, 10.1016/S1665-2681(19)31544-3 Ruffa, 2011, Cirrhotic cardiomyopathy evaluated with tissue Doppler imaging is not associated with the severity of liver dysfunction in liver cirrhosis, Gut, 241 Henriksen, 2003, Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease, Gut, 52, 1511, 10.1136/gut.52.10.1511 Ruiz-Del-Arbol, 2005, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 42, 439, 10.1002/hep.20766 Wong, 2001, Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?, Clin Sci (Lond), 101, 621, 10.1042/CS20010183 Sola, 2010, Renal and circulatory dysfunction in cirrhosis: current management and future perspectives, J Hepatol, 53, 1135, 10.1016/j.jhep.2010.08.001 Saner, 2011, High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients, Transpl Int, 24, 425, 10.1111/j.1432-2277.2011.01219.x Lang, 2005, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005 De, 2003, Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis, J Hepatol, 39, 315, 10.1016/S0168-8278(03)00271-X Raizada, 2007, Intracardiac and intrarenal renin–angiotensin systems: mechanisms of cardiovascular and renal effects, J Investig Med, 55, 341, 10.2310/6650.2007.00020 Cazzaniga, 2007, Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt, Gut, 56, 869, 10.1136/gut.2006.102467 Rabie, 2009, The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt, Am J Gastroenterol, 104, 2458, 10.1038/ajg.2009.321 Holt, 2011, Diastolic dysfunction defined by E/A ratio <1 on 2-D echo is an independent predictor of liver transplantation or death in patient with cirrhosis, J Hepatol, 54, S245, 10.1016/S0168-8278(11)60607-7 Therapondos, 2002, Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus, Liver Transpl, 8, 690, 10.1053/jlts.2002.34381 Torregrosa, 2005, Cardiac alterations in cirrhosis: reversibility after liver transplantation, J Hepatol, 42, 68, 10.1016/j.jhep.2004.09.008 Monin, 2001, Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography, J Am Coll Cardiol, 37, 2101, 10.1016/S0735-1097(01)01339-0 Hoffmann, 2010, Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease, Eur J Echocardiogr, 11, 544, 10.1093/ejechocard/jeq015 Cranney, 1990, Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography, Circulation, 82, 154, 10.1161/01.CIR.82.1.154 Lawton, 2011, Magnetic resonance imaging detects significant sex differences in human myocardial strain, Biomed Eng Online, 10.1186/1475-925X-10-76 Iles, 2008, Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping, J Am Coll Cardiol, 52, 1574, 10.1016/j.jacc.2008.06.049 Bernardi, 1998, Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors, Hepatology, 27, 28, 10.1002/hep.510270106 Bal, 2003, Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation, Liver Int, 23, 243, 10.1034/j.1600-0676.2003.00833.x Shin, 2011, Alterations in QT interval in patients undergoing living donor liver transplantation, Transplant Proc, 43, 170, 10.1016/j.transproceed.2010.12.002 Genovesi, 2009, QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium, Clin Sci (Lond), 116, 851, 10.1042/CS20080325 Hansen, 2007, Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes, J Hepatol, 47, 373, 10.1016/j.jhep.2007.03.013 Henriksen, 2002, Dyssynchronous electrical and mechanical systole in patients with cirrhosis, J Hepatol, 36, 513, 10.1016/S0168-8278(02)00010-7 Aljaroudi, 2011, Left ventricular dyssynchrony in patients with end-stage liver disease, J Nucl Cardiol, 18, 451, 10.1007/s12350-010-9332-1 Bernardi, 2012, QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?, Expert Rev Gastroenterol Hepatol, 6, 57, 10.1586/egh.11.86 Zambruni, 2006, Cardiac electrophysiological abnormalities in patients with cirrhosis, J Hepatol, 44, 994, 10.1016/j.jhep.2005.10.034 Trevisani, 2003, QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt, J Hepatol, 38, 461, 10.1016/S0168-8278(03)00057-6 Mani, 2008, Decreased heart rate variability in patients with cirrhosis relates to the presence and severity of hepatic encephalopathy, Am J Physiol Gastrointest Liver Physiol, 296, G330, 10.1152/ajpgi.90488.2008 Pateron, 1999, Elevated circulating cardiac troponin I in patients with cirrhosis, Hepatology, 29, 640, 10.1002/hep.510290332 Gøtze, 2006, BNP and N-terminal proBNP are both extracted in the normal kidney, Eur J Clin Invest, 36, 8, 10.1111/j.1365-2362.2006.01594.x Krag, 2010, Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites, Gut, 59, 105, 10.1136/gut.2009.180570 Gustot, 2009, Severe sepsis in cirrhosis, Hepatology, 50, 2022, 10.1002/hep.23264 Alqahtani, 2008, Cirrhotic cardiomyopathy, Semin Liver Dis, 28, 59, 10.1055/s-2008-1040321 Rössle, 2010, TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update, Gut, 59, 988, 10.1136/gut.2009.193227 Ruiz-Del-Arbol, 2003, Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology, 38, 1210, 10.1053/jhep.2003.50447 Krag, 2012, The cardiorenal link in advanced cirrhosis, Med Hypotheses, 79, 53, 10.1016/j.mehy.2012.03.032 Kovacs, 2009, Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results, Cardiovasc Intervent Radiol, 33, 290, 10.1007/s00270-009-9696-2 Gines, 2002, Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis, Gastroenterology, 123, 1839, 10.1053/gast.2002.37073 Ripoll, 2010, The heart in liver transplantation, J Hepatol, 54, 810, 10.1016/j.jhep.2010.11.003 Adigun, 2005, Effect of cirrhosis and liver transplantation on the gender difference in QT interval, Am J Cardiol, 95, 691, 10.1016/j.amjcard.2004.10.054 Henriksen, 2004, Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis, J Hepatol, 40, 239, 10.1016/j.jhep.2003.10.026 Zambruni, 2008, Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis, J Hepatol, 48, 415, 10.1016/j.jhep.2007.11.012 Kim, 2011, Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation, Transplant Proc, 43, 1654, 10.1016/j.transproceed.2011.02.017 Serste, 2010, Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites, Hepatology, 52, 1017, 10.1002/hep.23775